Article Versions Notes

Marcus R, Christopher W, Keller J, Nassoiy S, Chang S-C, Goldfarb M, Wolf R, Jutric Z. Systemic Therapy Is Associated with Improved Oncologic Outcomes in Resectable Stage II/III Intrahepatic Cholangiocarcinoma: An Examination of the National Cancer Database over the Past Decade. Cancers. 2022; 14(17):4320. https://doi.org/10.3390/cancers14174320

Marcus, Rebecca, Wade Christopher, Jennifer Keller, Sean Nassoiy, Shu-Ching Chang, Melanie Goldfarb, Ronald Wolf, and Zeljka Jutric. 2022. "Systemic Therapy Is Associated with Improved Oncologic Outcomes in Resectable Stage II/III Intrahepatic Cholangiocarcinoma: An Examination of the National Cancer Database over the Past Decade" Cancers 14, no. 17: 4320. https://doi.org/10.3390/cancers14174320

Marcus, R., Christopher, W., Keller, J., Nassoiy, S., Chang, S.-C., Goldfarb, M., Wolf, R., & Jutric, Z. (2022). Systemic Therapy Is Associated with Improved Oncologic Outcomes in Resectable Stage II/III Intrahepatic Cholangiocarcinoma: An Examination of the National Cancer Database over the Past Decade. Cancers, 14(17), 4320. https://doi.org/10.3390/cancers14174320